These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 27456102)
1. Impact of Chronic Kidney Disease on Risk for Vascular Events. Fan J; Salameh H Curr Vasc Pharmacol; 2016; 14(5):409-414. PubMed ID: 27456102 [TBL] [Abstract][Full Text] [Related]
2. A Population-Based Analysis of Quality Indicators in CKD. Manns L; Scott-Douglas N; Tonelli M; Weaver R; Tam-Tham H; Chong C; Hemmelgarn B Clin J Am Soc Nephrol; 2017 May; 12(5):727-733. PubMed ID: 28377473 [TBL] [Abstract][Full Text] [Related]
3. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease. Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176 [TBL] [Abstract][Full Text] [Related]
4. Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial. Kimura G; Kasahara M; Ueshima K; Tanaka S; Yasuno S; Fujimoto A; Sato T; Imamoto M; Kosugi S; Nakao K Clin Exp Nephrol; 2017 Jun; 21(3):417-424. PubMed ID: 27392909 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease and its relationship with chronic kidney disease. Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487 [TBL] [Abstract][Full Text] [Related]
8. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction? Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614 [TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials. Liu Y; Ma X; Zheng J; Jia J; Yan T BMC Nephrol; 2017 Jun; 18(1):206. PubMed ID: 28666408 [TBL] [Abstract][Full Text] [Related]
10. Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting. Völler H; Gitt A; Jannowitz C; Karoff M; Karmann B; Pittrow D; Reibis R; Hildemann S Eur J Prev Cardiol; 2014 Sep; 21(9):1125-33. PubMed ID: 23508927 [TBL] [Abstract][Full Text] [Related]
11. Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials. Zhang X; Xiang C; Zhou YH; Jiang A; Qin YY; He J BMC Cardiovasc Disord; 2014 Feb; 14():19. PubMed ID: 24529196 [TBL] [Abstract][Full Text] [Related]
12. [USE OF STATINS IN PATIENTS WITH CHRONIC KIDNEY DISEASE TO PREVENT CARDIOVASCULAR DISEASE]. Zavidić T; Lodeta B; Lovrinić Đ Acta Med Croatica; 2016 Dec; 70(4-5):301-7. PubMed ID: 29087163 [TBL] [Abstract][Full Text] [Related]
13. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials. Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation and application of estimation of glomerular filtration rate based on serum creatinine and cystatin C in renal function staging]. Shen ZX; Liu Y; Liu M; Zheng H; Wu XJ; Shen C Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1557-1562. PubMed ID: 29141349 [No Abstract] [Full Text] [Related]
16. HMG CoA reductase inhibitors and renoprotection: the weight of the evidence. Romayne Kurukulasuriya L; Athappan G; Saab G; Whaley Connell A; Sowers JR Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):49-59. PubMed ID: 19124395 [TBL] [Abstract][Full Text] [Related]
17. Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes. Clase CM; Barzilay J; Gao P; Smyth A; Schmieder RE; Tobe S; Teo KK; Yusuf S; Mann JF Kidney Int; 2017 Mar; 91(3):683-690. PubMed ID: 27927602 [TBL] [Abstract][Full Text] [Related]
18. Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry. Luk AO; Li X; Zhang Y; Guo X; Jia W; Li W; Weng J; Yang W; Chan WB; Ozaki R; Tsang CC; Mukhopadhyay M; Ojha AK; Hong EG; Yoon KH; Sobrepena L; Toledo RM; Duran M; Sheu W; Q Do T; Nguyen TK; Ma RC; Kong AP; Chow CC; Tong PC; So WY; Chan JC; Diabet Med; 2016 Sep; 33(9):1230-9. PubMed ID: 26511783 [TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia in Patients with Kidney Disease. Thobani A; Jacobson TA Cardiol Clin; 2021 Aug; 39(3):353-363. PubMed ID: 34247749 [TBL] [Abstract][Full Text] [Related]
20. Statins in chronic kidney disease and kidney transplantation. Kassimatis TI; Goldsmith DJ Pharmacol Res; 2014 Oct; 88():62-73. PubMed ID: 24995940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]